Department of Anesthesiology & Invasive Paintherapy, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands.
Neuromodulation. 2011 Jul-Aug;14(4):319-24; discussion 324-5. doi: 10.1111/j.1525-1403.2011.00368.x. Epub 2011 Jul 7.
To evaluate the clinical efficacy of pain suppression in back area and lower extremities by recently developed plate electrodes for spinal cord stimulation through percutaneous access.
A retrospective analysis is performed: 20 consecutive patients with both lower extremity pain and low back pain, with low back counting for at least 30% of the overall pain were implanted with a small profile plate type lead, S-Series (SJM), via percutaneous approach. Patients were asked to rate their back and leg pain as well as their overall satisfaction and data on quality of life (QOL) on a (0-10 point) visual analog scale (VAS) before and after implantation. Medication use, functional pain (pain when bending forward, moving), and patient satisfaction scores also were collected.
A significant reduction of 55% and 45.7% in, respectively, VAS legs and VAS back pain was found. One year postoperatively the reduction was still present, respectively, 43% and 27% for the legs and the back. In 17 patients (85%) a clinically relevant reduction (defined as reduction of 2 points or 30% in VAS) in back pain was seen, with a mean decrease of 4.3 points (2.0-10.0) or 52% (22-100). Only three patients had no reduction in back pain, although they had reduction of their pain in the lower extremities. A significant and clinically relevant improvement of 66% and 70% was seen, respectively, for general satisfaction and QOL, respectively. One year postoperatively this improvement was still present, respectively, 69% and 75% for the satisfaction and QOL. Importantly functional pain also decreased by 51%. No infections occurred. Mean duration of post-op wound pain was 13.5 hours.
Percutaneous implantation of the S-Series plate electrodes using a 10 gauge epidural needle combines the advantages of a minimal invasive technique with the possibility to cover the back area supplementing leg coverage in 85% of the failed back surgery syndrome patients.
评估通过经皮入路使用最近开发的脊髓刺激板状电极抑制背部和下肢疼痛的临床疗效。
回顾性分析:20 例下肢疼痛和腰痛患者,腰痛至少占总疼痛的 30%,采用经皮入路植入小轮廓板状 S 系列(SJM)导联。患者在植入前后使用(0-10 分)视觉模拟评分(VAS)分别对背部和腿部疼痛、整体满意度以及生活质量(QOL)数据进行评分。还收集了药物使用、功能疼痛(弯腰、活动时疼痛)和患者满意度评分。
腿部 VAS 和背部 VAS 疼痛分别显著降低 55%和 45.7%。术后 1 年仍存在分别为腿部和背部 43%和 27%的缓解。17 例患者(85%)背部疼痛有临床相关缓解(定义为 VAS 降低 2 分或 30%),平均降低 4.3 分(2.0-10.0)或 52%(22-100)。只有 3 名患者背部疼痛没有减轻,但下肢疼痛减轻。总体满意度和 QOL 分别显著改善 66%和 70%。术后 1 年,满意度和 QOL 分别为 69%和 75%,仍存在改善。重要的是,功能疼痛也降低了 51%。未发生感染。术后切口疼痛平均持续 13.5 小时。
使用 10 号硬膜外针经皮植入 S 系列板状电极,将微创技术的优势与覆盖背部区域的可能性相结合,在 85%的失败性脊柱手术综合征患者中补充腿部覆盖范围。